000 01382 a2200361 4500
005 20250518042933.0
264 0 _c20200817
008 202008s 0 0 eng d
022 _a1029-2403
024 7 _a10.1080/10428194.2019.1594217
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZackon, Alix Y L
245 0 0 _aMaximizing the effectiveness of oral therapies in lymphoid cancers: research gaps and unmet needs.
_h[electronic resource]
260 _bLeukemia & lymphoma
_c10 2019
300 _a2356-2364 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAdministration, Oral
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aClinical Trials as Topic
650 0 4 _aHumans
650 0 4 _aLeukemia, Lymphoid
_xdiagnosis
650 0 4 _aLymphoma
_xdiagnosis
650 0 4 _aMedication Adherence
650 0 4 _aTreatment Outcome
700 1 _aAyers, Amy A
700 1 _aYeager, Katherine A
700 1 _aSomma, Mary L
700 1 _aFriedberg, Jonathan W
700 1 _aFlowers, Christopher R
700 1 _aNastoupil, Loretta J
773 0 _tLeukemia & lymphoma
_gvol. 60
_gno. 10
_gp. 2356-2364
856 4 0 _uhttps://doi.org/10.1080/10428194.2019.1594217
_zAvailable from publisher's website
999 _c29764078
_d29764078